Viatris recalls Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division…

Recall date

August 23, 2021

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0851-2021

FDA classification

Class II

Brand / firm

Viatris

Sold / distributed

Nationwide within the United States

Why it was recalled

Failed Dissolution Specifications

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01